SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-23-000025
Filing Date
2023-11-02
Accepted
2023-11-02 16:16:31
Documents
46
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20230930.htm   iXBRL 10-Q 1106875
2 EX-31.1 exhibit311q323.htm EX-31.1 8907
3 EX-31.2 exhibit312q323.htm EX-31.2 9002
4 EX-32.1 exhibit321q323.htm EX-32.1 5190
5 EX-32.2 exhibit322q323.htm EX-32.2 5347
11 GRAPHIC vrna-20230930_g1.jpg GRAPHIC 385633
  Complete submission text file 0001657312-23-000025.txt   4519810

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20230930.xsd EX-101.SCH 22015
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20230930_cal.xml EX-101.CAL 43154
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20230930_def.xml EX-101.DEF 59575
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20230930_lab.xml EX-101.LAB 305234
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20230930_pre.xml EX-101.PRE 177929
40 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20230930_htm.xml XML 292251
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 231372535
SIC: 2834 Pharmaceutical Preparations